tiprankstipranks
Trending News
More News >
ABIONYX Pharma SA (FR:ABNX)
:ABNX
France Market

ABIONYX Pharma SA (ABNX) Financial Statements

Compare
5 Followers

ABIONYX Pharma SA Financial Overview

ABIONYX Pharma SA's market cap is currently €131.05M. The company's EPS TTM is €-0.066; its P/E ratio is -28.05; ABIONYX Pharma SA is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 4.60M€ 4.64M€ 5.25M€ 675.00K€ 0.00
Gross Profit€ 844.00K€ 618.00K€ 636.00K€ 259.00K€ -80.00K
Operating Income€ -5.57M€ -3.41M€ -4.11M€ -5.95M€ -3.58M
EBITDA€ -4.93M€ -4.84M€ -4.01M€ -7.42M€ -2.33M
Net Income€ -4.40M€ -3.52M€ -4.21M€ -5.82M€ -1.89M
Balance Sheet
Cash & Short-Term Investments€ 3.23M€ 4.10M€ 4.05M€ 7.93M€ 9.15M
Total Assets€ 13.45M€ 14.83M€ 15.82M€ 21.83M€ 10.29M
Total Debt€ 3.10M€ 3.39M€ 4.01M€ 4.96M€ 24.00K
Net Debt€ -137.00K€ -714.00K€ -33.00K€ -2.98M€ -9.13M
Total Liabilities€ 6.03M€ 6.91M€ 8.65M€ 11.15M€ 3.66M
Stockholders' Equity€ 7.42M€ 7.92M€ 7.17M€ 10.68M€ 6.63M
Cash Flow
Free Cash Flow€ -3.60M€ -3.83M€ -3.53M€ -6.86M€ -747.00K
Operating Cash Flow€ -3.60M€ -3.70M€ -3.36M€ -6.69M€ -599.00K
Investing Cash Flow€ -100.00K€ -130.00K€ -175.00K€ 1.34M€ -125.00K
Financing Cash Flow€ 2.80M€ 3.89M€ -194.00K€ 3.97M€ 1.55M
Currency in EUR

ABIONYX Pharma SA Earnings and Revenue History

ABIONYX Pharma SA Debt to Assets

ABIONYX Pharma SA Cash Flow

ABIONYX Pharma SA Forecast EPS vs Actual EPS